Cargando…
PO-1494 Universal testing for SARS-Cov-2 in patients undergoing anticancer treatment.
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ireland Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479304/ http://dx.doi.org/10.1016/S0167-8140(21)07945-7 |
| _version_ | 1784576225361002496 |
|---|---|
| author | Guerini, A.E. Magrini, S.M. Borghetti, P. Volpi, G. Luca, T. Costa, L. Pegurri, L. Guaineri, A. Imbrescia, J. Ranghetti, E. Premi, A. Donofrio, A. Spiazzi, L. Buglione, M. |
| author_facet | Guerini, A.E. Magrini, S.M. Borghetti, P. Volpi, G. Luca, T. Costa, L. Pegurri, L. Guaineri, A. Imbrescia, J. Ranghetti, E. Premi, A. Donofrio, A. Spiazzi, L. Buglione, M. |
| author_sort | Guerini, A.E. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8479304 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Ireland Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84793042021-09-29 PO-1494 Universal testing for SARS-Cov-2 in patients undergoing anticancer treatment. Guerini, A.E. Magrini, S.M. Borghetti, P. Volpi, G. Luca, T. Costa, L. Pegurri, L. Guaineri, A. Imbrescia, J. Ranghetti, E. Premi, A. Donofrio, A. Spiazzi, L. Buglione, M. Radiother Oncol Digital Poster: Other Elsevier Ireland Ltd. 2021-08 2021-09-28 /pmc/articles/PMC8479304/ http://dx.doi.org/10.1016/S0167-8140(21)07945-7 Text en Copyright © 2021 Elsevier Ireland Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Digital Poster: Other Guerini, A.E. Magrini, S.M. Borghetti, P. Volpi, G. Luca, T. Costa, L. Pegurri, L. Guaineri, A. Imbrescia, J. Ranghetti, E. Premi, A. Donofrio, A. Spiazzi, L. Buglione, M. PO-1494 Universal testing for SARS-Cov-2 in patients undergoing anticancer treatment. |
| title | PO-1494 Universal testing for SARS-Cov-2 in patients undergoing anticancer treatment. |
| title_full | PO-1494 Universal testing for SARS-Cov-2 in patients undergoing anticancer treatment. |
| title_fullStr | PO-1494 Universal testing for SARS-Cov-2 in patients undergoing anticancer treatment. |
| title_full_unstemmed | PO-1494 Universal testing for SARS-Cov-2 in patients undergoing anticancer treatment. |
| title_short | PO-1494 Universal testing for SARS-Cov-2 in patients undergoing anticancer treatment. |
| title_sort | po-1494 universal testing for sars-cov-2 in patients undergoing anticancer treatment. |
| topic | Digital Poster: Other |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479304/ http://dx.doi.org/10.1016/S0167-8140(21)07945-7 |
| work_keys_str_mv | AT gueriniae po1494universaltestingforsarscov2inpatientsundergoinganticancertreatment AT magrinism po1494universaltestingforsarscov2inpatientsundergoinganticancertreatment AT borghettip po1494universaltestingforsarscov2inpatientsundergoinganticancertreatment AT volpig po1494universaltestingforsarscov2inpatientsundergoinganticancertreatment AT lucat po1494universaltestingforsarscov2inpatientsundergoinganticancertreatment AT costal po1494universaltestingforsarscov2inpatientsundergoinganticancertreatment AT pegurril po1494universaltestingforsarscov2inpatientsundergoinganticancertreatment AT guaineria po1494universaltestingforsarscov2inpatientsundergoinganticancertreatment AT imbresciaj po1494universaltestingforsarscov2inpatientsundergoinganticancertreatment AT ranghettie po1494universaltestingforsarscov2inpatientsundergoinganticancertreatment AT premia po1494universaltestingforsarscov2inpatientsundergoinganticancertreatment AT donofrioa po1494universaltestingforsarscov2inpatientsundergoinganticancertreatment AT spiazzil po1494universaltestingforsarscov2inpatientsundergoinganticancertreatment AT buglionem po1494universaltestingforsarscov2inpatientsundergoinganticancertreatment |